Plenary 6: Emerging Strategies in AKI and Extracorporeal Support

20 Sep 2026 16:00 17:30

Room 1

Yu-Chang YEH Moderator

Time	Session

16:00 16:15	AKD Care Redefined: Diabetes, Hypertension, and Strategies for Long-Term Health VinCent Wu Speaker Room 1
16:15 16:30	Drug Exposures: Concerns in Kidney Safety (PPI vs Potassium-Competitive ACID Blockers (P-CABs)) Kyungho Lee Speaker Room 1
16:30 16:45	Acute PD vs Acute HD: Which Is the Right Choice? or Tropical Nephrology: Leptospirosis, Dengue, Malaria Nattachai Srisawat Speaker Precision Sepsis-AKI — Biomarkers, AI and Phenotyping in the Asia-PacificTiming of DialysisAcute PD vs Acute HD: Which Is the Right Choice? Room 1
16:45 17:00	Tackling Heterogeneity: Phenotyping for Hemadsorption or Defining What Matters in AKI Trials: Heterogeneity and Future Direction of Major Adverse Kidney Events Kent Doi Speaker Organ crosstalk in AKITargeted Polymyxin B Hemadsorption in Sepsis: Lessons from Japanese Experience and Patient Selection Room 1
17:00 17:20	Extracorporeal Therapies in Trauma, Burns and Cerebral Edema John Prowle Speaker Trajectories of Critical Illness – Defining Endotypes from Routine DataDynamic Prescription of CRRT Ready for Prime TimeAdapting CRRT for patients with Electrolyte and acid-base disordersExtracorporeal Therapies in Trauma, Burns and Cerebral Edema Room 1
17:20 17:30	Q & A Room 1